Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition
Crossref DOI link: https://doi.org/10.1186/s12885-016-2353-7
Published Online: 2016-05-17
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Davis, McKale R.
Daggett, Juliane J.
Pascual, Agnes S.
Lam, Jessica M.
Leyva, Kathryn J.
Cooper, Kimbal E.
Hull, Elizabeth E.
License valid from 2016-05-17